Revenue
-
Net Income
-$87.0M
▼ 40.5% YoY
EPS
$-2.38
▲ 59.1% YoY
Cash
$75.3M
▲ 52.6% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Hawryluk P. Kent President & CEO | Buy | Mar 13, 2026 | 18.5K | $28.41 | $526K | Form 4 ↗ |
Hawryluk P. Kent President & CEO | Vest | Feb 26, 2026 | 28.8K | $16.00 | $460K | Form 4 ↗ |
Azoulay Salomon Chief Medical Officer | Grant | Feb 2, 2026 | 15.0K | $0.00 | $0 | Form 4 ↗ |
Bartram Richard Chief Financial Officer | Grant | Feb 2, 2026 | 15.0K | $0.00 | $0 | Form 4 ↗ |
Hawryluk P. Kent President & CEO | Grant | Feb 2, 2026 | 35.3K | $0.00 | $0 | Form 4 ↗ |